Polycystic Ovary Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-35 years old; (2) Meeting the Rotterdam diagnostic criteria; (3) Willing to participate in the follow-up and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Menopause, pregnancy, lactation; (2) Exogenous hormones within 3 months, history of ovarian surgery, planned exogenous hormone therapy; (3) Suffering from other states or diseases that can affect heart rate, respiration, body temperature and sleep parameters: diseases of the cardiovascular system (hypertension, heart disease, arrhythmia, wearing a pacemaker, etc.), respiratory diseases, abnormalities of the thyroid function (hyperthyroidism/hypothyroidism, positive antibodies are not excluded), adrenal diseases, hyperprolactinemia, taking psychotropic medications; (4) Severe systemic disease or any unstable disease or medical condition that, according to medical criteria, may jeopardize patient safety and his/her compliance with the requirements of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| basal hormone;AMH; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstruation and fertility status;Life-style ;Socioeconomic status ;Sleeping habit;Height, weight, birth weight, waist circumference, hip circumference;The Polycystic Ovary Syndrome Questionnaire;Neurobehavioral Scale; | — |
Countries
China
Contacts
Obstetrics and Gynecology Hospital of Fudan University